{"schema_version":"secwatch.filing_event.v1","accession":"0001510964-22-000085","form_type":"8-K","ticker":"CVSI","cik":"0001510964","company_name":"CV Sciences, Inc.","filed_at":"2022-11-14T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.922986+00:00","generated_at":"2026-06-21T20:01:34.992511+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"CV Sciences Q3 2022 revenue down 27% YoY to $3.8M, operating loss narrowed to $0.9M","bullets":["Revenue $3.8M, down 27% from $5.1M; gross margin 41.6% vs 46.2%.","Operating loss improved to $0.9M from $3.0M; negative adjusted EBITDA $1.2M vs $2.7M.","Cash balance $1.1M; extinguished entire outstanding convertible debt.","Preliminary approval of settlement of six shareholder derivative lawsuits; continues strategic review including M&A.","Launched PlusCBD Reserve Collection; maintains #1 hemp extract brand in natural channel per SPINS."],"urls":{"canonical":"https://secwatch.observer/filing/0001510964-22-000085","json":"https://secwatch.observer/filing/0001510964-22-000085.json","markdown":"https://secwatch.observer/filing/0001510964-22-000085.md","text":"https://secwatch.observer/filing/0001510964-22-000085.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1510964/000151096422000085/0001510964-22-000085-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1510964/000151096422000085/cvsi-20221114.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T20:01:34.992511+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"03710ea4d967ecae40495f45b30081433b183520","claim":"CV Sciences, Inc. reported the quarter ended September 30, 2022 results: revenue $3.8 million.","evidence_excerpt":"today announced its financial results for the quarter ended September 30, 2022. Third Quarter 2022 and Recent Financial and Operating Highlights • Revenue of $3.8 million for third quarter of 2022","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1510964/000151096422000085/0001510964-22-000085-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter ended September 30, 2022"},{"label":"Revenue","value":"$3.8 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}